UK factory growth hits six-year high, but job cuts mount – business live | Business







8.03am EDT08:03

Lunchtime summary







7.44am EDT07:44

High street visits boosted by discount meal deal







7.18am EDT07:18







6.59am EDT06:59







6.53am EDT06:53

AstraZeneca has expanded an agreement with Oxford Biomedica to scale up production of its potential Covid-19 vaccine, as the race continues to find an effective prevention for the deadly virus.

Under the supply agreement, the Oxford-based cell and gene therapy firm said it would produce tens of millions of doses of AstraZeneca’s potential vaccine, AZD1222, for 18 months, which could be extended by a further 18 months into 2023.

It will be made at the firm’s three manufacturing suites at its new centre, Oxbox, in Oxford. Two of the suites will be ready to use in the next two months, earlier than expected. AstraZeneca will pay Oxford Biomedica £50m under the deal.

More here:







6.38am EDT06:38







6.09am EDT06:09







6.03am EDT06:03

Eurozone unemployment rises to 7.9%







5.48am EDT05:48







5.32am EDT05:32

Covid-19 drags eurozone back into deflation







5.17am EDT05:17

UK mortgage approvals jump







5.11am EDT05:11







5.07am EDT05:07







5.00am EDT05:00







4.41am EDT04:41

Apple overtakes FTSE 100







4.37am EDT04:37

UK factories keep cutting staff, despite recovery

Updated
at 5.20am EDT


Source link

Leave a Reply

Your email address will not be published. Required fields are marked *